This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Amgen Research (Munich) Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Inventor Spotlight: Susanne Mangold
Introduction
Susanne Mangold is a notable inventor based in Cham, Switzerland. With a focus on innovative biomedical solutions, she has made significant contributions to the field of antibody engineering. Her work emphasizes the intersection of immunology and therapeutic applications, showcasing her expertise and commitment to advancing medical research.
Latest Patents
Susanne holds a patent for a groundbreaking invention titled "Cross-species-specific PSMAxCD3 bispecific single chain antibody." This invention pertains to a unique bispecific single chain antibody molecule that contains a first binding domain capable of engaging with the CD3 epsilon chain of humans and non-chimpanzee primates, coupled with a second binding domain targeting the prostate-specific membrane antigen (PSMA). The patent also includes nucleic acids encoding the antibody, along with vectors, host cells, and a process for its production. Moreover, it details pharmaceutical compositions containing this bispecific antibody and its medical applications.
Career Highlights
Currently, Susanne is affiliated with Amgen Research (Munich) GmbH, where she plays a key role in the development of innovative biomedical therapies. Her research is instrumental in enhancing the effectiveness of targeted cancer treatments, particularly through her work on bispecific antibodies.
Collaborations
Throughout her career, Susanne has worked closely with prominent colleagues such as Peter Kufer and Tobias Raum. Their collaborative efforts have significantly advanced the understanding and application of bispecific antibody technology in the medical field.
Conclusion
In conclusion, Susanne Mangold's innovative contributions to antibody technology exemplify her dedication to advancing therapeutic options in healthcare. Her patent for the Cross-species-specific PSMAxCD3 bispecific single chain antibody stands as a testament to her skill and vision as an inventor, promising new avenues for treating diseases associated with PSMA.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile